Case Report: Cerebellar ataxia with serum anti-GluK2 positivity and a multiple system atrophy–like phenotype: a longitudinal diagnostic dilemma
Abstract
Anti-GluK2 antibody–associated neurologic disease is a rare neuronal antibody–associated syndrome that frequently involves the cerebellum, but its long-term clinical evolution remains poorly defined. We report a 53-year-old woman who initially presented predominantly with cerebellar ataxia. Brain MRI showed cerebellar atrophy and a hot cross bun sign. Serum anti-GluK2 IgG was detected twice, whereas cerebrospinal fluid (CSF) testing remained negative. Routine CSF studies and tumor screening were unremarkable, and genetic testing for hereditary ataxia identified no explanatory findings. Her gait improved following two courses of intravenous methylprednisolone pulse therapy, and an immune-mediated cerebellar syndrome remained the favored working diagnosis. During follow-up, anti-GluK2 antibodies became undetectable; however, ataxia subsequently worsened, accompanied by dysarthria, progressive cerebellar atrophy, bilateral middle cerebellar peduncle abnormalities, orthostatic hypotension, and increased postvoid residual urine volume. An exploratory serum quiescent seed amplification assay was positive, indicating α-synuclein seeding activity in the tested sample. These findings further increased clinical suspicion of multiple system atrophy of the cerebellar type (MSA-C). This case highlights the longitudinal challenges in distinguishing neuronal antibody-associated cerebellar ataxia from MSA-C-like neurodegeneration and underscores the need to reassess initial diagnoses as clinical, imaging, and laboratory evidence accumulates.
Related
- Hindbrain explants enable multimodal and longitudinal analysis of the developing olivo-cerebellar circuit at single-cell resolution
- SEZ6L2 antibody-associated cerebellar ataxia mimicking alcohol-related brain damage - diagnostic challenges and successful treatment with double filtration plasmapheresis and glucocorticoids: a case report
- Longitudinal Impacts of Sex-Steroid Hormones on Cerebellar Structure in Adulthood are Sex Differentiated
- Multiple Basal Cell Carcinomas in an Adolescent with an MLPA-Detected PTCH1-Region Deletion and a Gorlin-Goltz Phenotype
- HPOQuest: A Rare-Disease Diagnostic Agent Using Active Phenotype Acquisition
BibTeX
@article{he2026case,
title = {{Case Report: Cerebellar ataxia with serum anti-GluK2 positivity and a multiple system atrophy–like phenotype: a longitudinal diagnostic dilemma}},
author = {Liuchang He and Lu Cong and Zunjing Liu and Min Cheng},
journal = {Frontiers in Immunology},
year = {2026},
month = nov,
doi = {10.3389/fimmu.2026.1974711},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1974711},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Case Report: Cerebellar ataxia with serum anti-GluK2 positivity and a multiple system atrophy–like phenotype: a longitudinal diagnostic dilemma
AU - Liuchang He
AU - Lu Cong
AU - Zunjing Liu
AU - Min Cheng
PY - 2026
DA - 2026/11/16
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1974711
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1974711
AB - Anti-GluK2 antibody–associated neurologic disease is a rare neuronal antibody–associated syndrome that frequently involves the cerebellum, but its long-term clinical evolution remains poorly defined. We report a 53-year-old woman who initially presented predominantly with cerebellar ataxia. Brain MRI showed cerebellar atrophy and a hot cross bun sign. Serum anti-GluK2 IgG was detected twice, whereas cerebrospinal fluid (CSF) testing remained negative. Routine CSF studies and tumor screening were unremarkable, and genetic testing for hereditary ataxia identified no explanatory findings. Her gait improved following two courses of intravenous methylprednisolone pulse therapy, and an immune-mediated cerebellar syndrome remained the favored working diagnosis. During follow-up, anti-GluK2 antibodies became undetectable; however, ataxia subsequently worsened, accompanied by dysarthria, progressive cerebellar atrophy, bilateral middle cerebellar peduncle abnormalities, orthostatic hypotension, and increased postvoid residual urine volume. An exploratory serum quiescent seed amplification assay was positive, indicating α-synuclein seeding activity in the tested sample. These findings further increased clinical suspicion of multiple system atrophy of the cerebellar type (MSA-C). This case highlights the longitudinal challenges in distinguishing neuronal antibody-associated cerebellar ataxia from MSA-C-like neurodegeneration and underscores the need to reassess initial diagnoses as clinical, imaging, and laboratory evidence accumulates.
SN - 1664-3224
ER -